This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Kazunori Morokuma: Innovator in Pertussis Vaccine Development
Introduction
Kazunori Morokuma is a notable inventor based in Houtaku, Japan. He has made significant contributions to the field of vaccine development, particularly in the preparation of pertussis toxin toxoid. His innovative methods have the potential to enhance vaccine safety and efficacy.
Latest Patents
Kazunori Morokuma holds a patent for a method for preparing pertussis toxin toxoid using HcHo and amino acids. This patent discloses a method that involves treating pertussis toxin with formaldehyde in the presence of lysine or glycine combined with N-acetyltriptophan. The resultant toxoid does not exhibit toxicity reversion, making it highly suitable for use in pertussis vaccines. He has 1 patent to his name.
Career Highlights
Throughout his career, Morokuma has worked with esteemed organizations such as the Chemo-Sero-Therapeutic Research Institute and Akihiro Ginnaga. His work has been instrumental in advancing the understanding and development of vaccines.
Collaborations
Some of his notable coworkers include Katsutoshi Aihara and Mitsuo Sakoh. Their collaborative efforts have contributed to the success of various projects in the field of vaccine research.
Conclusion
Kazunori Morokuma's innovative approach to vaccine development, particularly in the preparation of pertussis toxin toxoid, showcases his commitment to enhancing public health. His contributions are vital in the ongoing efforts to improve vaccine safety and effectiveness.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile